Willkie Farr & Gallagher advised FFL Partners and Accordion, while Ropes & Gray advised Charlesbank and Gibson, Dunn & Crutcher advised Motive on the deal. FFL...
Charlesbank Capital Partners and Motive Partners’ Investment in Accordion Partners
Cullinan Oncology’s Collaboration with Taiho Pharmaceutical
Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan...
H.I.G. Capital’s Acquisition of Pixelle Specialty Solutions
Ropes & Gray represented H.I.G. Capital in the transaction, while Cravath represented Lindsay Goldberg. H.I.G. Capital announced its acquisition of Pixelle Specialty Solutions, a specialty papers...
McNally Capital’s Investment in the Smith & Oby Company
Ropes & Gray represented McNally Capital in the transaction. McNally Capital executed its investment The Smith & Oby Company, a leading Midwest HVAC and plumbing mechanical contractor...
Blackstone’s $1.3 Billion Acquisition of International Data Group
Simpson Thacher represented Blackstone in the transaction while Mintz advised International Data Group. Blackstone announced its proposed acquisition of International Data Group, Inc. (“IDG”) from Oriental Rainbow...
Q2 Solutions’ Acquisition of Myriad RBM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
Q2 Solutions’ Acquisition of Myriad RBM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
Nuvve’s $750 Million Joint Venture with Stonepeak Partners LP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Nuvve on the deal, while Kirkland & Ellis counseled Stonepeak Partners. Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a...